Teresa Latham
Cincinnati Children's Hospital Medical Center(US)
Publications by Year
Research Areas
Hemoglobinopathies and Related Disorders, Iron Metabolism and Disorders, Myeloproliferative Neoplasms: Diagnosis and Treatment, Blood groups and transfusion, Prenatal Screening and Diagnostics
Most-Cited Works
- → Hydroxyurea for Children with Sickle Cell Anemia in Sub-Saharan Africa(2018)362 cited
- → Novel use Of Hydroxyurea in an African Region with Malaria (NOHARM): a trial for children with sickle cell anemia(2017)145 cited
- → Hydroxyurea Dose Escalation for Sickle Cell Anemia in Sub-Saharan Africa(2020)145 cited
- → Hydroxyurea Therapy for Children With Sickle Cell Anemia in Sub‐Saharan Africa: Rationale and Design of the REACH Trial(2015)64 cited
- → Realizing effectiveness across continents with hydroxyurea: Enrollment and baseline characteristics of the multicenter REACH study in Sub‐Saharan Africa(2018)39 cited
- → Hydroxyurea to lower transcranial Doppler velocities and prevent primary stroke: the Uganda NOHARM sickle cell anemia cohort(2019)39 cited
- → Hydroxyurea with dose escalation for primary stroke risk reduction in children with sickle cell anaemia in Tanzania (SPHERE): an open-label, phase 2 trial(2023)32 cited
- → Surveillance for sickle cell disease, United Republic of Tanzania(2020)31 cited
- → Hydroxyurea treatment is associated with lower malaria incidence in children with sickle cell anemia in sub-Saharan Africa(2022)28 cited
- → Hydroxycarbamide treatment reduces transcranial Doppler velocity in the absence of transfusion support in children with sickle cell anaemia, elevated transcranial Doppler velocity, and cerebral vasculopathy: the EXTEND trial(2021)25 cited